HELP · NASDAQ · Medical - Pharmaceuticals

Helus Pharma (HELP)

Develops investigational serotonergic therapies for depression and generalized anxiety disorder.

$12.90
vs last close−0.81 (−5.91%)

Something off on this page? Send us feedback.

Next report
Nov 12, 26
in 50 days
EPS estimate
−$0.67
Revenue estimate
Fiscal quarter
Q2 FY27

EPSReportedEstimate

Feb '25Jul '25Aug '25Nov '25Feb '26Jun '26Aug '26Nov '26
Reported−$0.37−$1.01−$1.10−$1.39−$0.99−$0.96−$0.91Pending
Estimate−$0.73−$0.85−$0.96−$0.74−$0.53−$1.04−$0.84−$0.67
Surprise+49.5%−18.7%−14.7%−87.8%−87.3%+8.1%−8.8%

RevenueReportedEstimate

Feb '25Jul '25Aug '25Nov '25Feb '26Jun '26Aug '26Nov '26
Reported$1.3MPending
Estimate
Surprise

HistoryUpcoming

Date / PeriodEstimateReportedSurprise
Mar 2028−$0.37
Dec 2027−$0.57
Sep 2027−$0.58
Jun 2027−$0.60
Mar 2027−$0.62
Dec 2026−$0.62
Nov 2026−$0.67
Aug 2026−$0.84−$0.91−8.8%
Jun 2026−$1.04−$0.96+8.1%
Feb 2026−$0.53−$0.99−87.3%
Nov 2025−$0.74−$1.39−87.8%
Aug 2025
Jul 2025
Feb 2025
Nov 2024
Aug 2024
Jun 2024
Mar 2024
Feb 2024
Nov 2023
Aug 2023
Mar 2023
Feb 2023
Nov 2022
Aug 2022
Mar 2022
Feb 2022
Nov 2021
Aug 2021
Mar 2021
Dec 2020
Oct 2020
Jun 2020
Dec 2019

The latest year is open to everyone — the 23 quarters behind it read with an account.

Date / PeriodEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Mar 2028−$0.37$8.6M
Dec 2027−$0.57$0
Sep 2027−$0.58$0
Jun 2027−$0.60$0
Mar 2027−$0.62$0
Dec 2026−$0.62$0
Nov 12, 2026−$0.67$0
Aug 14, 2026−$0.84−$0.91−8.8%+4.7%
Jun 30, 2026−$1.04−$0.96+8.1%$1.3M−3.9%
Feb 13, 2026−$0.53−$0.99−87.3%+2.9%
Nov 13, 2025−$0.74−$1.39−87.8%
Aug 13, 2025
Jul 1, 2025
Feb 11, 2025
Nov 13, 2024
Aug 8, 2024
Jun 25, 2024
Mar 31, 2024
Feb 14, 2024
Nov 15, 2023
Aug 14, 2023
Mar 31, 2023
Feb 14, 2023
Nov 14, 2022
Aug 8, 2022
Mar 31, 2022
Feb 10, 2022
Nov 15, 2021
Aug 16, 2021
Mar 31, 2021
Dec 31, 2020
Oct 31, 2020
Jun 30, 2020
Dec 31, 2019

The latest year is open to everyone — the 23 quarters behind it read with an account.